Macrogenics MGNX
NASDAQ MGNX
$3.86 +0.09 (+2.39%)
At close: Sep 30, 2026 · 4:00 PM EDT

Macrogenics (MGNX) Preferred Shares (2012 - 2013)

Updated

Macrogenics (MGNX) reported Preferred Shares of $2.95 million for Q3 2013.

Analysis

Macrogenics (MGNX) Preferred Shares (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Macrogenics 245.67 Mn -72.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 2.95 Mn
Dec 31, 2012 2.95 Mn
API Access

Macrogenics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=MGNX&period=max&api_key=YOUR_API_KEY